Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples
Articolo
Data di Pubblicazione:
2023
Citazione:
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples / Redegalli, M., Grassini, G., Magliacane, G., Pecciarini, L., Schiavo Lena, M., Smart, C.E., Johnston, R.L., Waddell, N., Maestro, R., Macchini, M., Orsi, G., Petrone, M.C., Rossi, G., Balzano, G., Falconi, M., Arcidiacono, P.G., Reni, M., Doglioni, C., Cangi, M.G.. - In: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. - ISSN 1542-3565. - 21:11(2023), pp. 2825-2833. [10.1016/j.cgh.2022.10.014]
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease, for which it is crucial to promptly detect actionable and prognostic alterations to drive specific therapeutic decisions, regardless of tumor resectability status. Endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) is of key importance for PDAC diagnosis and can contribute significantly to tumor molecular profiling.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
BRCA; Cytology; EUS-FNA; Molecular Profile; NGS; PDAC; Precision Medicine; Resectable; Unresectable
Elenco autori:
Redegalli, Miriam; Grassini, Greta; Magliacane, Gilda; Pecciarini, Lorenza; Schiavo Lena, Marco; Smart, Chanel E; Johnston, Rebecca L; Waddell, Nicola; Maestro, Roberta; Macchini, Marina; Orsi, Giulia; Petrone, Maria Chiara; Rossi, Gemma; Balzano, Gianpaolo; Falconi, Massimo; Arcidiacono, Paolo G; Reni, Michele; Doglioni, Claudio; Cangi, Maria Giulia
Link alla scheda completa:
Pubblicato in: